Discover

Big Pharma, Big Dividends

Established drug makers paying big dividends.

Large pharma combines defensive, cash-generative franchises with substantial dividends. This collection screens established drug manufacturers yielding 3%+ — income with a healthcare tilt — ranked by yield.

29 stocksSorted by dividend yieldUpdated 16 Jul 2026

Why it matters

Established drug makers paying big dividends. This group spans defensive demand, consumer behaviour, rates exposure and innovation, so business-model quality matters more than the label.

What to check next

Compare pricing power, repeat demand, margins, regulatory risk and the sensitivity of each company to interest rates or consumer weakness.

Main risk

A theme can hide very different risk profiles: biotech, insurers, online retail and property all respond to different drivers.

Company	Market Cap	Reward	Risk	Yield
Shionogi & Co. LtdSGIOF	$18.3B	—	—	43.6%
SSY Group LimitedLJUIF	$1.2B	—	—	36.0%
The United Laboratories International Holdings LimitedULIHF	$3.5B	—	—	27.5%
CSPC Pharmaceutical Group LtdCHJTF	$15.9B	—	—	21.8%
Livzon Pharmaceutical Group IncLVZPF	$4.6B	—	—	21.1%
H. Lundbeck A/SHLUBF	$7.1B	—	—	19.7%
Shanghai Fosun Pharmaceutical (Group) Co. LtdSFOSF	$9.8B	—	—	15.0%
Recordati Industria Chimica e Farmaceutica S.p.A.RICFY	$11.3B	—	—	9.5%
Sanofi ADRSNY	$117.5B	—	—	8.5%
Perrigo Company PLCPRGO	$1.8B	—	—	8.2%
Hansoh Pharmaceutical Group Company LimitedHNSPF	$28.3B	—	—	7.6%
Merck KGaA ADRMKKGY	$65.0B	—	—	7.4%
Hikma Pharmaceuticals PLCHIK	£2.8B	47	43	6.7%
Pfizer IncPFE	$154.0B	—	—	6.3%
Hypera SAHYPMY	$3.0B	—	—	5.9%
Sihuan Pharmaceutical Holdings Group LtdSHPHF	$1.9B	—	—	5.9%
Kaken Pharmaceutical Co. LtdKKPCF	$1.1B	—	—	5.0%
Novo Nordisk A/SNVO	$169.6B	—	—	4.9%
Orion Oyj ADRORINY	$11.4B	—	—	4.4%
Bristol-Myers Squibb CompanyBMY	$117.6B	—	—	4.3%
Organon & CoOGN	$2.0B	—	—	4.2%
Integrated Cannabis Company IncCRPGF	$3.5B	—	—	3.7%
Astellas Pharma IncALPMF	$26.4B	—	—	3.6%
Takeda Pharmaceutical Co Ltd ADRTAK	$59.2B	—	—	3.5%
Ipsen SA ADRIPSEY	$13.3B	—	—	3.5%
AbbVie IncABBV	$356.5B	—	—	3.3%
Eisai Co. LtdESALF	$9.4B	—	—	3.3%
Ono Pharmaceutical Co LtdOPHLY	$8.0B	—	—	3.1%
GlaxoSmithKline PLC ADRGSK	$119.5B	—	—	3.0%

Shionogi & Co. LtdSGIOF · $18.3B
Reward—Risk—Yield43.6%
SSY Group LimitedLJUIF · $1.2B
Reward—Risk—Yield36.0%
The United Laboratories International Holdings LimitedULIHF · $3.5B
Reward—Risk—Yield27.5%
CSPC Pharmaceutical Group LtdCHJTF · $15.9B
Reward—Risk—Yield21.8%
Livzon Pharmaceutical Group IncLVZPF · $4.6B
Reward—Risk—Yield21.1%
H. Lundbeck A/SHLUBF · $7.1B
Reward—Risk—Yield19.7%
Shanghai Fosun Pharmaceutical (Group) Co. LtdSFOSF · $9.8B
Reward—Risk—Yield15.0%
Recordati Industria Chimica e Farmaceutica S.p.A.RICFY · $11.3B
Reward—Risk—Yield9.5%
Sanofi ADRSNY · $117.5B
Reward—Risk—Yield8.5%
Perrigo Company PLCPRGO · $1.8B
Reward—Risk—Yield8.2%
Hansoh Pharmaceutical Group Company LimitedHNSPF · $28.3B
Reward—Risk—Yield7.6%
Merck KGaA ADRMKKGY · $65.0B
Reward—Risk—Yield7.4%
Hikma Pharmaceuticals PLCHIK · £2.8B
Reward47Risk43Yield6.7%
Pfizer IncPFE · $154.0B
Reward—Risk—Yield6.3%
Hypera SAHYPMY · $3.0B
Reward—Risk—Yield5.9%
Sihuan Pharmaceutical Holdings Group LtdSHPHF · $1.9B
Reward—Risk—Yield5.9%
Kaken Pharmaceutical Co. LtdKKPCF · $1.1B
Reward—Risk—Yield5.0%
Novo Nordisk A/SNVO · $169.6B
Reward—Risk—Yield4.9%
Orion Oyj ADRORINY · $11.4B
Reward—Risk—Yield4.4%
Bristol-Myers Squibb CompanyBMY · $117.6B
Reward—Risk—Yield4.3%
Organon & CoOGN · $2.0B
Reward—Risk—Yield4.2%
Integrated Cannabis Company IncCRPGF · $3.5B
Reward—Risk—Yield3.7%
Astellas Pharma IncALPMF · $26.4B
Reward—Risk—Yield3.6%
Takeda Pharmaceutical Co Ltd ADRTAK · $59.2B
Reward—Risk—Yield3.5%
Ipsen SA ADRIPSEY · $13.3B
Reward—Risk—Yield3.5%
AbbVie IncABBV · $356.5B
Reward—Risk—Yield3.3%
Eisai Co. LtdESALF · $9.4B
Reward—Risk—Yield3.3%
Ono Pharmaceutical Co LtdOPHLY · $8.0B
Reward—Risk—Yield3.1%
GlaxoSmithKline PLC ADRGSK · $119.5B
Reward—Risk—Yield3.0%

Frequently asked questions

What is the Big Pharma, Big Dividends collection?

Established drug makers paying big dividends. It currently holds 29 stocks, each rated by Openbook's Reward and Risk scores. Large pharma combines defensive, cash-generative franchises with substantial dividends.

How are Big Pharma, Big Dividends stocks selected?

Constituents are chosen by a rules-based screen over the full UK and US common-stock universe, then ranked by market capitalisation.

How often is the Big Pharma, Big Dividends list updated?

It is rebuilt from live market data, so the constituents and their rankings update as prices and company fundamentals change — there is no fixed, hand-edited list.

How should I use the Reward and Risk ratings?

Openbook's Reward rating combines a stock's growth, momentum, profitability and valuation into a single 0–100 score, and the Risk rating scores financial strength, volatility and size. Use them to compare names within this theme — broadly, a higher Reward alongside a lower Risk is more attractive. They are quantitative research signals, not investment advice.

Openbook Reward and Risk ratings and factor scores are quantitative signals for research, not investment advice. Data may be delayed. Some US-listed names carry partial factor coverage.